Meeting
2021 ASCO Annual Meeting
Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.
Authors
Nicole Margo Grogan
University of Michigan Rogel Cancer Center, Ann Arbor, MI
Nicole Margo Grogan , Yi-Mi Wu , Dan R. Robinson , James M. Rae , Norah Lynn Henry , Daniel F. Hayes , Michelle F. Jacobs , Kara J. Milliron , Bailey Hulswit , Lauren E. Hipp , Sofia Merajver , Elena Martinez Stoffel , Arul Chinnaiyan , Erin Frances Cobain
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10527)
DOI
10.1200/JCO.2021.39.15_suppl.10527
Abstract #
10527
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinical impact of pathogenic germline variants in pancreatic cancer: Results from a multicenter prospective universal genetic testing study.
First Author: Pedro Luiz Serrano Uson Junior
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2018 ASCO Annual Meeting
Non-BRCA hereditary gene mutations and breast cancer phenotype: An ISC-RAM Consortia study.
First Author: Banu Arun
Poster
2017 Genitourinary Cancers Symposium
Inherited pathologic mutations and family history in patients with prostate cancer.
First Author: Shuwen Lin